tiprankstipranks
Trending News
More News >
Maravai Lifesciences Holdings (MRVI)
NASDAQ:MRVI
US Market

Maravai Lifesciences Holdings (MRVI) Income Statement

Compare
393 Followers

Maravai Lifesciences Holdings Income Statement

Last quarter (Q4 2024), Maravai Lifesciences Holdings's total revenue was $56.41M, a decrease of -23.92% from the same quarter last year. In Q4, Maravai Lifesciences Holdings's net income was $-26.14M. See Maravai Lifesciences Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 259.19M$ 288.94M$ 883.00M$ 799.24M$ 284.10M
Gross Profit
$ 108.31M$ 140.20M$ 714.04M$ 658.68M$ 204.45M
Operating Expenses
$ 343.93M$ 171.85M$ 147.63M$ 115.28M$ 103.55M
Depreciation and Amortization
$ 56.87M$ 48.78M$ 38.10M$ 24.75M$ 25.84M
EBITDA
$ -156.92M$ 712.41M$ 609.99M$ 585.78M$ 138.27M
Operating Income
$ -235.62M$ -31.65M$ 574.22M$ 554.64M$ 67.60M
Other Income/Expenses
$ -25.86M$ 649.38M$ -22.74M$ -23.88M$ -22.09M
Pretax Income
$ -261.48M$ 617.74M$ 551.47M$ 530.76M$ 81.70M
Net Income
$ -144.85M$ -119.03M$ 490.66M$ 469.25M$ 76.89M
Per Share Metrics
Basic EPS
$ -1.05$ -0.90$ 3.73$ 4.09$ 0.80
Diluted EPS
$ -1.05$ -0.90$ 1.92$ 1.82$ 0.70
Weighted Average Shares Outstanding
137.91M 131.92M 131.54M 114.79M 96.65M
Weighted Average Shares Outstanding (Diluted)
137.91M 131.92M 255.32M 257.80M 96.65M
Currency in USD

Maravai Lifesciences Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis